- Thread Author
- #1
Health authorities at the World Health Organization (WHO) and the regional Communicable Disease Center are sounding a global alarm over the rapid spread of a new, highly drug-resistant strain of Plasmodium falciparum malaria across mainland Southeast Asia.
Dubbed "Super Malaria" by researchers, this strain has demonstrated resistance to artemisinin—the core compound in the world's most effective frontline treatment, Artemisinin-based Combination Therapies (ACTs)—as well as to the partner drugs used in those combinations. This effectively renders the standard first- and second-line treatments obsolete in areas where the strain is prevalent, primarily in the border regions
Dubbed "Super Malaria" by researchers, this strain has demonstrated resistance to artemisinin—the core compound in the world's most effective frontline treatment, Artemisinin-based Combination Therapies (ACTs)—as well as to the partner drugs used in those combinations. This effectively renders the standard first- and second-line treatments obsolete in areas where the strain is prevalent, primarily in the border regions